DR BRIAN MEHLING

Dr. Brian Mehling, MD

Orthopedic Surgeon and Stem Cell Specialist

Dr. Brian Mehling is the founder and Chief Medical Officer of Blue Horizon International, LLC. Dr. Mehling is also a world-renowned orthopedic trauma surgeon whose mainstay of practice is in the greater New York City metropolitan area. Dr. Mehling completed his residency in Orthopedic Surgery at The St. Joseph’s Hospital, Patterson, New Jersey and performed his fellowship in sports medicine at Graduate Hospital, Philadelphia, Pennsylvania. He is an alumnus of The Ohio State University and also holds a Master’s of Science Degree in Biochemistry.

Blue Horizon International is a health care consulting company which combines cutting edge medical treatment and research with philanthropy. BHI provides resources and services to children and adults of all backgrounds, but especially those who are medically under-served. Dr. Mehling first conceived the Blue Horizon International Hospital concept while appraising differences in medical healthcare standards throughout Asia and the Middle East. Dr. Mehling recognized the truly significant need for universally high quality benchmarks in foreign nations and surmised that bringing the world’s best physicians to regions abroad would advance the standard of healthcare world-wide. In addition, American Nationals traveling in foreign lands would be able to receive the same quality of healthcare they have grown to expect at home. In association with Blue Horizon International, Blue Horizon’s Stem Cell Therapy Program provides an opportunity for the global community to participate in groundbreaking research while receiving stem cell therapy via state-of-the-art procedures provided in today’s western hospital safety conditions.

Uniquely positioned to take advantage of its clinical research, BHSC has safely and efficiently treated more than 600 patients with over 2,600 regenerative procedures documenting each procedure while tracking the progress of patients through their treatment cycle. Blue Horizon International Stem Cell Therapy Program is associated with The Stem Cell Centre, Hongqiao Brain Hospital and Wuhan University School of Basic Medical Science, Wuhan, China.

Dr Brian Mehling is Chairman of  Blue Horizon Charitable Foundation (BHCF). The Blue Horizon Charitable Foundation is a recognized 501 (c) (3) organization, dedicated to increasing the awareness of global inequalities in healthcare, as well as providing charitable medical care and education to adults and children in impoverished areas. The foundation raises capital in order to support medical centers and clinics by providing medicines vital to basic human survival, by performing advanced medical treatments otherwise not accessible to certain geographic regions, and to finance research and development in stem cell therapies and cellular regenerative medicine. BHCF also supports children around the world who have been orphaned as a result of disease and/or war. In order to raise awareness of these situations, BHCF produces documentary films that bring much needed attention to the plight of those with limited or no access to healthcare. The provision of these resources to less developed areas enables the medically underserved to benefit from high quality care and treatment.

Dr Mehling is also a documentary film producer and  President and CEO of Industrial Motion Pictures (IMP) , that produced the film Tiny Tears, debuting at the prestigious Cannes Film Festival.